Revision of Daniel J. Drucker

system · 2026-09-08 08:01:05Z · syncWikidata sync

Changes

Field	Before	After
Image	~~98295~~	164382
Subtitle	~~Professor of Medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto.~~	Canadian endocrinologist
Description	—	Daniel Joshua Drucker is a Canadian endocrinologist renowned for his breakthrough discoveries of the biological actions of glucagon-like peptides GLP-1 and GLP-2, including GLP-1's key role in stimulating glucose-dependent insulin secretion, reducing food intake, protecting the heart, and reducing systemic inflammation. His scientific research has been a driving force in GLP-1's journey from a newly discovered peptide sequence to the mechanism behind globally used and life-changing therapeutics for type 2 diabetes and obesity. It has also driven transformative new therapeutics for intestinal failure and other metabolic disorders. A Fellow of the Royal Society, and laureate of the 2023 Wolf Prize in Medicine, he is a University Professor of Medicine at the University of Toronto and Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto.
Type	—	person

Added handles